[
  {
    "title": "John Hancock Global Shareholder Yield Fund Q4 2024 Commentary",
    "published": 1740740100,
    "day_prices": {
      "2025-02-28T14:30:00+00:00": 205.1199951171875,
      "2025-02-28T15:30:00+00:00": 205.35000610351562,
      "2025-02-28T16:30:00+00:00": 205.39999389648438,
      "2025-02-28T17:30:00+00:00": 205.4199981689453,
      "2025-02-28T18:30:00+00:00": 205.5,
      "2025-02-28T19:30:00+00:00": 206.38499450683594,
      "2025-02-28T20:30:00+00:00": 206.65499877929688
    },
    "sentiment": 0.9335291385650635
  },
  {
    "title": "Drug Stocks Are the New Safe Bet in a Shaky Market",
    "published": 1740726000,
    "day_prices": {
      "2025-02-28T14:30:00+00:00": 205.1199951171875,
      "2025-02-28T15:30:00+00:00": 205.35000610351562,
      "2025-02-28T16:30:00+00:00": 205.39999389648438,
      "2025-02-28T17:30:00+00:00": 205.4199981689453,
      "2025-02-28T18:30:00+00:00": 205.5,
      "2025-02-28T19:30:00+00:00": 206.38499450683594,
      "2025-02-28T20:30:00+00:00": 206.65499877929688
    },
    "sentiment": 0.39812377095222473
  },
  {
    "title": "2025 Dividend Kings - Off To A Strong Start",
    "published": 1740596821,
    "day_prices": {
      "2025-02-26T14:30:00+00:00": 203.58999633789062,
      "2025-02-26T15:30:00+00:00": 203.39500427246094,
      "2025-02-26T16:30:00+00:00": 203.31500244140625,
      "2025-02-26T17:30:00+00:00": 202.9149932861328,
      "2025-02-26T18:30:00+00:00": 202.9647979736328,
      "2025-02-26T19:30:00+00:00": 203.625,
      "2025-02-26T20:30:00+00:00": 203.1999969482422
    },
    "sentiment": 0.9469028115272522
  },
  {
    "title": "Miller-Howard Income-Equity Q4 2024 Commentary",
    "published": 1740548700,
    "day_prices": {
      "2025-02-26T14:30:00+00:00": 203.58999633789062,
      "2025-02-26T15:30:00+00:00": 203.39500427246094,
      "2025-02-26T16:30:00+00:00": 203.31500244140625,
      "2025-02-26T17:30:00+00:00": 202.9149932861328,
      "2025-02-26T18:30:00+00:00": 202.9647979736328,
      "2025-02-26T19:30:00+00:00": 203.625,
      "2025-02-26T20:30:00+00:00": 203.1999969482422
    },
    "sentiment": 0.9354743361473083
  },
  {
    "title": "Don't Get Left Behind - The Great Rotation Into Dividend Stocks Is Here",
    "published": 1740382200,
    "day_prices": {
      "2025-02-24T14:30:00+00:00": 201.8300018310547,
      "2025-02-24T15:30:00+00:00": 204.77499389648438,
      "2025-02-24T16:30:00+00:00": 203.9499969482422,
      "2025-02-24T17:30:00+00:00": 205.0,
      "2025-02-24T18:30:00+00:00": 204.99000549316406,
      "2025-02-24T19:30:00+00:00": 205.18629455566406,
      "2025-02-24T20:30:00+00:00": 204.7100067138672
    },
    "sentiment": 0.9179391264915466
  },
  {
    "title": "Ariel Investments Ariel Global Fund Q4 2024 Commentary",
    "published": 1740347820,
    "day_prices": {},
    "sentiment": 0.9343224763870239
  },
  {
    "title": "How To Invest $100,000 In A Near-Perfect Portfolio",
    "published": 1740211200,
    "day_prices": {},
    "sentiment": 0.9204853177070618
  },
  {
    "title": "Why Novo Nordisk Is A Strong Buy Despite Market Concerns",
    "published": 1740009540,
    "day_prices": {
      "2025-02-19T14:30:00+00:00": 196.7899932861328,
      "2025-02-19T15:30:00+00:00": 197.0500030517578,
      "2025-02-19T16:30:00+00:00": 197.25999450683594,
      "2025-02-19T17:30:00+00:00": 196.94020080566406,
      "2025-02-19T18:30:00+00:00": 197.4324951171875,
      "2025-02-19T19:30:00+00:00": 197.5449981689453,
      "2025-02-19T20:30:00+00:00": 197.5399932861328
    },
    "sentiment": 0.6987162828445435
  },
  {
    "title": "My Dividend Stock Portfolio: New January Dividend Record - 100 Holdings With 14 Buys",
    "published": 1739952600,
    "day_prices": {
      "2025-02-19T14:30:00+00:00": 196.7899932861328,
      "2025-02-19T15:30:00+00:00": 197.0500030517578,
      "2025-02-19T16:30:00+00:00": 197.25999450683594,
      "2025-02-19T17:30:00+00:00": 196.94020080566406,
      "2025-02-19T18:30:00+00:00": 197.4324951171875,
      "2025-02-19T19:30:00+00:00": 197.5449981689453,
      "2025-02-19T20:30:00+00:00": 197.5399932861328
    },
    "sentiment": 0.8562964797019958
  },
  {
    "title": "Genmab: Positive 2025 Outlook, Johnson & Johnson's Decision Coming Soon",
    "published": 1739845553,
    "day_prices": {
      "2025-02-18T14:30:00+00:00": 192.0,
      "2025-02-18T15:30:00+00:00": 195.25999450683594,
      "2025-02-18T16:30:00+00:00": 196.0050048828125,
      "2025-02-18T17:30:00+00:00": 196.47900390625,
      "2025-02-18T18:30:00+00:00": 196.27999877929688,
      "2025-02-18T19:30:00+00:00": 196.6894073486328,
      "2025-02-18T20:30:00+00:00": 196.7949981689453
    },
    "sentiment": 0.92885822057724
  },
  {
    "title": "Why Regeneron's Price May Soon Break Out",
    "published": 1739742843,
    "day_prices": {},
    "sentiment": 0.8815574645996094
  },
  {
    "title": "SCHD Is So Boring, And Big Changes Are In Store",
    "published": 1739552936,
    "day_prices": {
      "2025-02-14T14:30:00+00:00": 193.9499969482422,
      "2025-02-14T15:30:00+00:00": 194.83999633789062,
      "2025-02-14T16:30:00+00:00": 193.9600067138672,
      "2025-02-14T17:30:00+00:00": 194.3061981201172,
      "2025-02-14T18:30:00+00:00": 193.69000244140625,
      "2025-02-14T19:30:00+00:00": 193.6300048828125,
      "2025-02-14T20:30:00+00:00": 193.48989868164062
    },
    "sentiment": 0.6860861778259277
  },
  {
    "title": "AbbVie Names CEO Robert Michael Chairman as Richard Gonzalez Retires",
    "published": 1739525760,
    "day_prices": {
      "2025-02-14T14:30:00+00:00": 193.9499969482422,
      "2025-02-14T15:30:00+00:00": 194.83999633789062,
      "2025-02-14T16:30:00+00:00": 193.9600067138672,
      "2025-02-14T17:30:00+00:00": 194.3061981201172,
      "2025-02-14T18:30:00+00:00": 193.69000244140625,
      "2025-02-14T19:30:00+00:00": 193.6300048828125,
      "2025-02-14T20:30:00+00:00": 193.48989868164062
    },
    "sentiment": 0.894798219203949
  },
  {
    "title": "Janus Henderson Global Life Sciences Diversified ADR Managed Account Q4 2024 Commentary",
    "published": 1739480280,
    "day_prices": {
      "2025-02-13T14:30:00+00:00": 194.27999877929688,
      "2025-02-13T15:30:00+00:00": 193.15499877929688,
      "2025-02-13T16:30:00+00:00": 193.3800048828125,
      "2025-02-13T17:30:00+00:00": 193.34219360351562,
      "2025-02-13T18:30:00+00:00": 192.97999572753906,
      "2025-02-13T19:30:00+00:00": 193.66000366210938,
      "2025-02-13T20:30:00+00:00": 193.89999389648438
    },
    "sentiment": 0.9473699927330017
  },
  {
    "title": "IGA: Good Diversification And Fully-Covered Distribution (Rating Upgrade)",
    "published": 1739377566,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 190.5,
      "2025-02-12T15:30:00+00:00": 193.63999938964844,
      "2025-02-12T16:30:00+00:00": 193.5500030517578,
      "2025-02-12T17:30:00+00:00": 193.3699951171875,
      "2025-02-12T18:30:00+00:00": 191.8800048828125,
      "2025-02-12T19:30:00+00:00": 192.1300048828125,
      "2025-02-12T20:30:00+00:00": 192.50999450683594
    },
    "sentiment": 0.8406534194946289
  },
  {
    "title": "AbbVie, Xilio Therapeutics Set Collaboration, Option-To-License Agreement",
    "published": 1739347020,
    "day_prices": {
      "2025-02-12T14:30:00+00:00": 190.5,
      "2025-02-12T15:30:00+00:00": 193.63999938964844,
      "2025-02-12T16:30:00+00:00": 193.5500030517578,
      "2025-02-12T17:30:00+00:00": 193.3699951171875,
      "2025-02-12T18:30:00+00:00": 191.8800048828125,
      "2025-02-12T19:30:00+00:00": 192.1300048828125,
      "2025-02-12T20:30:00+00:00": 192.50999450683594
    },
    "sentiment": 0.8326743841171265
  },
  {
    "title": "Axsome Settling Teva Patent Litigation Is Another Positive Catalyst -- Upgrade",
    "published": 1739294443,
    "day_prices": {
      "2025-02-11T14:30:00+00:00": 189.8000030517578,
      "2025-02-11T15:30:00+00:00": 189.97999572753906,
      "2025-02-11T16:30:00+00:00": 191.20559692382812,
      "2025-02-11T17:30:00+00:00": 190.72000122070312,
      "2025-02-11T18:30:00+00:00": 191.05499267578125,
      "2025-02-11T19:30:00+00:00": 191.42999267578125,
      "2025-02-11T20:30:00+00:00": 191.63999938964844
    },
    "sentiment": 0.6216502785682678
  },
  {
    "title": "Income Strategy: I'm Stashing Cash Into These Wonderful Dividends",
    "published": 1739001600,
    "day_prices": {},
    "sentiment": 0.9171582460403442
  },
  {
    "title": "AbbVie Inc. stock underperforms Friday when compared to competitors",
    "published": 1738945920,
    "day_prices": {
      "2025-02-07T14:30:00+00:00": 193.16000366210938,
      "2025-02-07T15:30:00+00:00": 192.8000030517578,
      "2025-02-07T16:30:00+00:00": 191.65499877929688,
      "2025-02-07T17:30:00+00:00": 192.4149932861328,
      "2025-02-07T18:30:00+00:00": 191.8101043701172,
      "2025-02-07T19:30:00+00:00": 191.5500030517578,
      "2025-02-07T20:30:00+00:00": 190.85000610351562
    },
    "sentiment": 0.9331448078155518
  },
  {
    "title": "Bristol Myers Earnings Are a \u2018Tale of 2 Trends\u2019 as Guidance Falls Short. The Stock Is Falling",
    "published": 1738830300,
    "day_prices": {
      "2025-02-06T14:30:00+00:00": 191.89999389648438,
      "2025-02-06T15:30:00+00:00": 192.1699981689453,
      "2025-02-06T16:30:00+00:00": 193.00999450683594,
      "2025-02-06T17:30:00+00:00": 192.97900390625,
      "2025-02-06T18:30:00+00:00": 194.24989318847656,
      "2025-02-06T19:30:00+00:00": 193.8300018310547,
      "2025-02-06T20:30:00+00:00": 193.4600067138672
    },
    "sentiment": 0.7980320453643799
  },
  {
    "title": "Big Pharma, Bigger Bargain: Why Merck Stock Is Too Cheap To Ignore (Upgrade)",
    "published": 1738680260,
    "day_prices": {
      "2025-02-04T14:30:00+00:00": 187.6300048828125,
      "2025-02-04T15:30:00+00:00": 187.47999572753906,
      "2025-02-04T16:30:00+00:00": 189.91909790039062,
      "2025-02-04T17:30:00+00:00": 190.78900146484375,
      "2025-02-04T18:30:00+00:00": 190.84890747070312,
      "2025-02-04T19:30:00+00:00": 190.6475067138672,
      "2025-02-04T20:30:00+00:00": 189.83999633789062
    },
    "sentiment": 0.8916252255439758
  },
  {
    "title": "AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results",
    "published": 1738573595,
    "day_prices": {
      "2025-02-03T14:30:00+00:00": 183.17999267578125,
      "2025-02-03T15:30:00+00:00": 188.73500061035156,
      "2025-02-03T16:30:00+00:00": 188.9600067138672,
      "2025-02-03T17:30:00+00:00": 190.25,
      "2025-02-03T18:30:00+00:00": 189.64999389648438,
      "2025-02-03T19:30:00+00:00": 191.08999633789062,
      "2025-02-03T20:30:00+00:00": 190.16000366210938
    },
    "sentiment": 0.8980695605278015
  },
  {
    "title": "Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors",
    "published": 1743310800,
    "day_prices": {},
    "sentiment": 0.735475480556488
  },
  {
    "title": "PGIM Jennison Focused Value Fund Q4 2024 Commentary",
    "published": 1743206760,
    "day_prices": {},
    "sentiment": 0.9384081959724426
  },
  {
    "title": "AbbVie Vs. Sanofi: Which Is The Better Investment Right Now",
    "published": 1743155082,
    "day_prices": {
      "2025-03-28T13:30:00+00:00": 202.72999572753906,
      "2025-03-28T14:30:00+00:00": 202.72999572753906,
      "2025-03-28T15:30:00+00:00": 203.1199951171875,
      "2025-03-28T16:30:00+00:00": 204.60000610351562,
      "2025-03-28T17:30:00+00:00": 204.71499633789062,
      "2025-03-28T18:30:00+00:00": 204.9550018310547,
      "2025-03-28T19:30:00+00:00": 205.5
    },
    "sentiment": 0.8270342350006104
  },
  {
    "title": "LENZ Therapeutics Stock Is Attractive Before PDUFA",
    "published": 1743096791,
    "day_prices": {
      "2025-03-27T13:30:00+00:00": 202.02000427246094,
      "2025-03-27T14:30:00+00:00": 202.1699981689453,
      "2025-03-27T15:30:00+00:00": 203.44650268554688,
      "2025-03-27T16:30:00+00:00": 202.25999450683594,
      "2025-03-27T17:30:00+00:00": 201.97500610351562,
      "2025-03-27T18:30:00+00:00": 201.89999389648438,
      "2025-03-27T19:30:00+00:00": 202.11000061035156
    },
    "sentiment": 0.7770214080810547
  },
  {
    "title": "VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug",
    "published": 1743078660,
    "day_prices": {
      "2025-03-27T13:30:00+00:00": 202.02000427246094,
      "2025-03-27T14:30:00+00:00": 202.1699981689453,
      "2025-03-27T15:30:00+00:00": 203.44650268554688,
      "2025-03-27T16:30:00+00:00": 202.25999450683594,
      "2025-03-27T17:30:00+00:00": 201.97500610351562,
      "2025-03-27T18:30:00+00:00": 201.89999389648438,
      "2025-03-27T19:30:00+00:00": 202.11000061035156
    },
    "sentiment": 0.7798414826393127
  },
  {
    "title": "AbbVie (NYSE:ABBV) Showcases Oncology Innovations Amidst 6% Share Price Dip",
    "published": 1743011166,
    "day_prices": {
      "2025-03-26T13:30:00+00:00": 203.11500549316406,
      "2025-03-26T14:30:00+00:00": 202.00999450683594,
      "2025-03-26T15:30:00+00:00": 200.99000549316406,
      "2025-03-26T16:30:00+00:00": 201.3300018310547,
      "2025-03-26T17:30:00+00:00": 201.52999877929688,
      "2025-03-26T18:30:00+00:00": 202.30160522460938,
      "2025-03-26T19:30:00+00:00": 201.1300048828125
    },
    "sentiment": 0.702643632888794
  },
  {
    "title": "AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025",
    "published": 1742992200,
    "day_prices": {
      "2025-03-26T13:30:00+00:00": 203.11500549316406,
      "2025-03-26T14:30:00+00:00": 202.00999450683594,
      "2025-03-26T15:30:00+00:00": 200.99000549316406,
      "2025-03-26T16:30:00+00:00": 201.3300018310547,
      "2025-03-26T17:30:00+00:00": 201.52999877929688,
      "2025-03-26T18:30:00+00:00": 202.30160522460938,
      "2025-03-26T19:30:00+00:00": 201.1300048828125
    },
    "sentiment": 0.6275386810302734
  },
  {
    "title": "2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income",
    "published": 1742985000,
    "day_prices": {
      "2025-03-26T13:30:00+00:00": 203.11500549316406,
      "2025-03-26T14:30:00+00:00": 202.00999450683594,
      "2025-03-26T15:30:00+00:00": 200.99000549316406,
      "2025-03-26T16:30:00+00:00": 201.3300018310547,
      "2025-03-26T17:30:00+00:00": 201.52999877929688,
      "2025-03-26T18:30:00+00:00": 202.30160522460938,
      "2025-03-26T19:30:00+00:00": 201.1300048828125
    },
    "sentiment": 0.4989035427570343
  },
  {
    "title": "Trump turbulence stalls large pharma and biotech deals, bankers say",
    "published": 1742968800,
    "day_prices": {
      "2025-03-26T13:30:00+00:00": 203.11500549316406,
      "2025-03-26T14:30:00+00:00": 202.00999450683594,
      "2025-03-26T15:30:00+00:00": 200.99000549316406,
      "2025-03-26T16:30:00+00:00": 201.3300018310547,
      "2025-03-26T17:30:00+00:00": 201.52999877929688,
      "2025-03-26T18:30:00+00:00": 202.30160522460938,
      "2025-03-26T19:30:00+00:00": 201.1300048828125
    },
    "sentiment": 0.8095665574073792
  },
  {
    "title": "These Dividend Aristocrats\u2019 Stocks Can Protect You From the Market Selloff",
    "published": 1742922780,
    "day_prices": {
      "2025-03-25T13:30:00+00:00": 209.22000122070312,
      "2025-03-25T14:30:00+00:00": 205.46249389648438,
      "2025-03-25T15:30:00+00:00": 204.57000732421875,
      "2025-03-25T16:30:00+00:00": 202.30999755859375,
      "2025-03-25T17:30:00+00:00": 202.15499877929688,
      "2025-03-25T18:30:00+00:00": 201.00750732421875,
      "2025-03-25T19:30:00+00:00": 199.7899932861328
    },
    "sentiment": 0.9068983197212219
  },
  {
    "title": "3 Healthcare Stocks in the Doghouse",
    "published": 1742907701,
    "day_prices": {
      "2025-03-25T13:30:00+00:00": 209.22000122070312,
      "2025-03-25T14:30:00+00:00": 205.46249389648438,
      "2025-03-25T15:30:00+00:00": 204.57000732421875,
      "2025-03-25T16:30:00+00:00": 202.30999755859375,
      "2025-03-25T17:30:00+00:00": 202.15499877929688,
      "2025-03-25T18:30:00+00:00": 201.00750732421875,
      "2025-03-25T19:30:00+00:00": 199.7899932861328
    },
    "sentiment": 0.6724955439567566
  },
  {
    "title": "AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why",
    "published": 1742852714,
    "day_prices": {
      "2025-03-24T13:30:00+00:00": 209.38999938964844,
      "2025-03-24T14:30:00+00:00": 210.0749969482422,
      "2025-03-24T15:30:00+00:00": 210.5399932861328,
      "2025-03-24T16:30:00+00:00": 208.97999572753906,
      "2025-03-24T17:30:00+00:00": 208.9600067138672,
      "2025-03-24T18:30:00+00:00": 207.99000549316406,
      "2025-03-24T19:30:00+00:00": 208.30999755859375
    },
    "sentiment": 0.5732598900794983
  },
  {
    "title": "Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks",
    "published": 1742806869,
    "day_prices": {
      "2025-03-24T13:30:00+00:00": 209.38999938964844,
      "2025-03-24T14:30:00+00:00": 210.0749969482422,
      "2025-03-24T15:30:00+00:00": 210.5399932861328,
      "2025-03-24T16:30:00+00:00": 208.97999572753906,
      "2025-03-24T17:30:00+00:00": 208.9600067138672,
      "2025-03-24T18:30:00+00:00": 207.99000549316406,
      "2025-03-24T19:30:00+00:00": 208.30999755859375
    },
    "sentiment": 0.9282217025756836
  },
  {
    "title": "Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.",
    "published": 1742794403,
    "day_prices": {
      "2025-03-24T13:30:00+00:00": 209.38999938964844,
      "2025-03-24T14:30:00+00:00": 210.0749969482422,
      "2025-03-24T15:30:00+00:00": 210.5399932861328,
      "2025-03-24T16:30:00+00:00": 208.97999572753906,
      "2025-03-24T17:30:00+00:00": 208.9600067138672,
      "2025-03-24T18:30:00+00:00": 207.99000549316406,
      "2025-03-24T19:30:00+00:00": 208.30999755859375
    },
    "sentiment": 0.48902860283851624
  },
  {
    "title": "SCHD: Good Times Aren't Great (Rating Downgrade)",
    "published": 1742724000,
    "day_prices": {},
    "sentiment": 0.7561357617378235
  },
  {
    "title": "2025 Dividend Kings: Strong Run Continues",
    "published": 1742561991,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 211.72999572753906,
      "2025-03-21T14:30:00+00:00": 210.50999450683594,
      "2025-03-21T15:30:00+00:00": 210.75999450683594,
      "2025-03-21T16:30:00+00:00": 210.5,
      "2025-03-21T17:30:00+00:00": 209.87179565429688,
      "2025-03-21T18:30:00+00:00": 209.77000427246094,
      "2025-03-21T19:30:00+00:00": 208.9499969482422
    },
    "sentiment": 0.9449778199195862
  },
  {
    "title": "Merck Vs. Bristol-Myers Squibb: Which Pharma Stock Should You Buy",
    "published": 1742541707,
    "day_prices": {
      "2025-03-21T13:30:00+00:00": 211.72999572753906,
      "2025-03-21T14:30:00+00:00": 210.50999450683594,
      "2025-03-21T15:30:00+00:00": 210.75999450683594,
      "2025-03-21T16:30:00+00:00": 210.5,
      "2025-03-21T17:30:00+00:00": 209.87179565429688,
      "2025-03-21T18:30:00+00:00": 209.77000427246094,
      "2025-03-21T19:30:00+00:00": 208.9499969482422
    },
    "sentiment": 0.9369224905967712
  },
  {
    "title": "Defensive Stocks For Unpredictable Trump Policy",
    "published": 1742469633,
    "day_prices": {
      "2025-03-20T13:30:00+00:00": 213.00999450683594,
      "2025-03-20T14:30:00+00:00": 212.10499572753906,
      "2025-03-20T15:30:00+00:00": 211.61000061035156,
      "2025-03-20T16:30:00+00:00": 211.8800048828125,
      "2025-03-20T17:30:00+00:00": 211.6300048828125,
      "2025-03-20T18:30:00+00:00": 211.49000549316406,
      "2025-03-20T19:30:00+00:00": 211.27000427246094
    },
    "sentiment": 0.9074294567108154
  },
  {
    "title": "Invesco Health Care Fund Q4 2024 Commentary",
    "published": 1742461500,
    "day_prices": {
      "2025-03-20T13:30:00+00:00": 213.00999450683594,
      "2025-03-20T14:30:00+00:00": 212.10499572753906,
      "2025-03-20T15:30:00+00:00": 211.61000061035156,
      "2025-03-20T16:30:00+00:00": 211.8800048828125,
      "2025-03-20T17:30:00+00:00": 211.6300048828125,
      "2025-03-20T18:30:00+00:00": 211.49000549316406,
      "2025-03-20T19:30:00+00:00": 211.27000427246094
    },
    "sentiment": 0.944513738155365
  },
  {
    "title": "3 Dividend Stocks to Buy for Reliable Passive Income",
    "published": 1742383800,
    "day_prices": {
      "2025-03-19T13:30:00+00:00": 214.02999877929688,
      "2025-03-19T14:30:00+00:00": 212.1999969482422,
      "2025-03-19T15:30:00+00:00": 211.58999633789062,
      "2025-03-19T16:30:00+00:00": 212.14500427246094,
      "2025-03-19T17:30:00+00:00": 211.39999389648438,
      "2025-03-19T18:30:00+00:00": 210.97500610351562,
      "2025-03-19T19:30:00+00:00": 212.25999450683594
    },
    "sentiment": 0.8856502175331116
  },
  {
    "title": "AbbVie upgraded to Buy at Erste Group on Friday",
    "published": 1742304007,
    "day_prices": {
      "2025-03-18T13:30:00+00:00": 214.47000122070312,
      "2025-03-18T14:30:00+00:00": 214.7100067138672,
      "2025-03-18T15:30:00+00:00": 213.72000122070312,
      "2025-03-18T16:30:00+00:00": 213.22999572753906,
      "2025-03-18T17:30:00+00:00": 212.7322998046875,
      "2025-03-18T18:30:00+00:00": 213.13499450683594,
      "2025-03-18T19:30:00+00:00": 213.63999938964844
    },
    "sentiment": 0.6187431812286377
  },
  {
    "title": "AbbVie - ELAHERE Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients",
    "published": 1742210291,
    "day_prices": {
      "2025-03-17T13:30:00+00:00": 212.22000122070312,
      "2025-03-17T14:30:00+00:00": 213.58999633789062,
      "2025-03-17T15:30:00+00:00": 212.9499969482422,
      "2025-03-17T16:30:00+00:00": 214.25999450683594,
      "2025-03-17T17:30:00+00:00": 214.6699981689453,
      "2025-03-17T18:30:00+00:00": 214.86000061035156,
      "2025-03-17T19:30:00+00:00": 215.0500030517578
    },
    "sentiment": 0.9565293192863464
  },
  {
    "title": "The Zacks Analyst Blog Highlights AbbVie, Lockheed Martin, Dell and Hamilton Beach Brands",
    "published": 1742205960,
    "day_prices": {
      "2025-03-17T13:30:00+00:00": 212.22000122070312,
      "2025-03-17T14:30:00+00:00": 213.58999633789062,
      "2025-03-17T15:30:00+00:00": 212.9499969482422,
      "2025-03-17T16:30:00+00:00": 214.25999450683594,
      "2025-03-17T17:30:00+00:00": 214.6699981689453,
      "2025-03-17T18:30:00+00:00": 214.86000061035156,
      "2025-03-17T19:30:00+00:00": 215.0500030517578
    },
    "sentiment": 0.9374939799308777
  },
  {
    "title": "AbbVie (NYSE:ABBV) Reports ELAHERE Success in Phase 3 Trials for Platinum-Resistant Ovarian Cancer",
    "published": 1742145409,
    "day_prices": {},
    "sentiment": 0.9398689866065979
  },
  {
    "title": "ELAHERE\u00ae (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients",
    "published": 1742040000,
    "day_prices": {},
    "sentiment": 0.954433023929596
  },
  {
    "title": "Top Analyst Reports for AbbVie, Lockheed Martin & Dell",
    "published": 1741985220,
    "day_prices": {
      "2025-03-14T13:30:00+00:00": 209.77999877929688,
      "2025-03-14T14:30:00+00:00": 211.77999877929688,
      "2025-03-14T15:30:00+00:00": 212.4600067138672,
      "2025-03-14T16:30:00+00:00": 211.25,
      "2025-03-14T17:30:00+00:00": 211.19500732421875,
      "2025-03-14T18:30:00+00:00": 211.25999450683594,
      "2025-03-14T19:30:00+00:00": 211.13999938964844
    },
    "sentiment": 0.9361547827720642
  },
  {
    "title": "3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now",
    "published": 1741945860,
    "day_prices": {
      "2025-03-14T13:30:00+00:00": 209.77999877929688,
      "2025-03-14T14:30:00+00:00": 211.77999877929688,
      "2025-03-14T15:30:00+00:00": 212.4600067138672,
      "2025-03-14T16:30:00+00:00": 211.25,
      "2025-03-14T17:30:00+00:00": 211.19500732421875,
      "2025-03-14T18:30:00+00:00": 211.25999450683594,
      "2025-03-14T19:30:00+00:00": 211.13999938964844
    },
    "sentiment": 0.9174067974090576
  },
  {
    "title": "AbbVie Is Preparing To Challenge Eli Lilly And Novo Nordisk",
    "published": 1741881328,
    "day_prices": {
      "2025-03-13T13:30:00+00:00": 212.0,
      "2025-03-13T14:30:00+00:00": 212.97000122070312,
      "2025-03-13T15:30:00+00:00": 212.67999267578125,
      "2025-03-13T16:30:00+00:00": 211.89999389648438,
      "2025-03-13T17:30:00+00:00": 212.47000122070312,
      "2025-03-13T18:30:00+00:00": 212.0800018310547,
      "2025-03-13T19:30:00+00:00": 212.0399932861328
    },
    "sentiment": 0.5365036725997925
  },
  {
    "title": "Why AbbVie Inc. (ABBV) is the Best Pharma Stock to Buy According to Hedge Funds",
    "published": 1741804652,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 212.0,
      "2025-03-12T14:30:00+00:00": 213.22999572753906,
      "2025-03-12T15:30:00+00:00": 212.3249969482422,
      "2025-03-12T16:30:00+00:00": 213.26499938964844,
      "2025-03-12T17:30:00+00:00": 213.3800048828125,
      "2025-03-12T18:30:00+00:00": 212.75,
      "2025-03-12T19:30:00+00:00": 212.89999389648438
    },
    "sentiment": 0.8733941912651062
  },
  {
    "title": "Caterpillar: Diversification Without Diworsification; Home Depot Looks Healthy, So Do Others",
    "published": 1741786147,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 212.0,
      "2025-03-12T14:30:00+00:00": 213.22999572753906,
      "2025-03-12T15:30:00+00:00": 212.3249969482422,
      "2025-03-12T16:30:00+00:00": 213.26499938964844,
      "2025-03-12T17:30:00+00:00": 213.3800048828125,
      "2025-03-12T18:30:00+00:00": 212.75,
      "2025-03-12T19:30:00+00:00": 212.89999389648438
    },
    "sentiment": 0.8469449877738953
  },
  {
    "title": "Worried About a Market Meltdown? 2 Dividend Stocks to Own Forever.",
    "published": 1741777800,
    "day_prices": {
      "2025-03-12T13:30:00+00:00": 212.0,
      "2025-03-12T14:30:00+00:00": 213.22999572753906,
      "2025-03-12T15:30:00+00:00": 212.3249969482422,
      "2025-03-12T16:30:00+00:00": 213.26499938964844,
      "2025-03-12T17:30:00+00:00": 213.3800048828125,
      "2025-03-12T18:30:00+00:00": 212.75,
      "2025-03-12T19:30:00+00:00": 212.89999389648438
    },
    "sentiment": 0.9252632856369019
  },
  {
    "title": "Why AbbVie (ABBV) Dipped More Than Broader Market Today",
    "published": 1741729516,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 216.66000366210938,
      "2025-03-11T14:30:00+00:00": 215.09930419921875,
      "2025-03-11T15:30:00+00:00": 213.75,
      "2025-03-11T16:30:00+00:00": 213.17999267578125,
      "2025-03-11T17:30:00+00:00": 212.77999877929688,
      "2025-03-11T18:30:00+00:00": 214.2100067138672,
      "2025-03-11T19:30:00+00:00": 214.375
    },
    "sentiment": 0.8031525015830994
  },
  {
    "title": "These 10 stocks beating the market\u2019s recent Trump slump have this in common",
    "published": 1741700400,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 216.66000366210938,
      "2025-03-11T14:30:00+00:00": 215.09930419921875,
      "2025-03-11T15:30:00+00:00": 213.75,
      "2025-03-11T16:30:00+00:00": 213.17999267578125,
      "2025-03-11T17:30:00+00:00": 212.77999877929688,
      "2025-03-11T18:30:00+00:00": 214.2100067138672,
      "2025-03-11T19:30:00+00:00": 214.375
    },
    "sentiment": 0.8532666563987732
  },
  {
    "title": "BMEZ: Recession Fears Making You Sick? Buy This High-Yield Healthcare Fund",
    "published": 1741698125,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 216.66000366210938,
      "2025-03-11T14:30:00+00:00": 215.09930419921875,
      "2025-03-11T15:30:00+00:00": 213.75,
      "2025-03-11T16:30:00+00:00": 213.17999267578125,
      "2025-03-11T17:30:00+00:00": 212.77999877929688,
      "2025-03-11T18:30:00+00:00": 214.2100067138672,
      "2025-03-11T19:30:00+00:00": 214.375
    },
    "sentiment": 0.8730357885360718
  },
  {
    "title": "AbbVie Inc. (ABBV): A Magnificent Dividend Growth Stock to Invest In",
    "published": 1741682258,
    "day_prices": {
      "2025-03-11T13:30:00+00:00": 216.66000366210938,
      "2025-03-11T14:30:00+00:00": 215.09930419921875,
      "2025-03-11T15:30:00+00:00": 213.75,
      "2025-03-11T16:30:00+00:00": 213.17999267578125,
      "2025-03-11T17:30:00+00:00": 212.77999877929688,
      "2025-03-11T18:30:00+00:00": 214.2100067138672,
      "2025-03-11T19:30:00+00:00": 214.375
    },
    "sentiment": 0.8643693923950195
  },
  {
    "title": "Is AbbVie Inc. (ABBV) the Best Performing Dividend Stock to Buy Now?",
    "published": 1741635636,
    "day_prices": {
      "2025-03-10T13:30:00+00:00": 209.99000549316406,
      "2025-03-10T14:30:00+00:00": 216.72000122070312,
      "2025-03-10T15:30:00+00:00": 217.94000244140625,
      "2025-03-10T16:30:00+00:00": 218.22000122070312,
      "2025-03-10T17:30:00+00:00": 217.86000061035156,
      "2025-03-10T18:30:00+00:00": 217.7449951171875,
      "2025-03-10T19:30:00+00:00": 217.4199981689453
    },
    "sentiment": 0.7850075364112854
  },
  {
    "title": "This Top Dividend Stock Just Entered The Weight Loss Market: Is It a Buy?",
    "published": 1741607820,
    "day_prices": {
      "2025-03-10T13:30:00+00:00": 209.99000549316406,
      "2025-03-10T14:30:00+00:00": 216.72000122070312,
      "2025-03-10T15:30:00+00:00": 217.94000244140625,
      "2025-03-10T16:30:00+00:00": 218.22000122070312,
      "2025-03-10T17:30:00+00:00": 217.86000061035156,
      "2025-03-10T18:30:00+00:00": 217.7449951171875,
      "2025-03-10T19:30:00+00:00": 217.4199981689453
    },
    "sentiment": 0.9157766103744507
  },
  {
    "title": "A Major Market Rotation Is Likely Coming",
    "published": 1741431600,
    "day_prices": {},
    "sentiment": 0.5134666562080383
  },
  {
    "title": "Fidelity Equity-Income Fund Q4 2024 Review",
    "published": 1741264020,
    "day_prices": {
      "2025-03-06T14:30:00+00:00": 211.4499969482422,
      "2025-03-06T15:30:00+00:00": 210.1300048828125,
      "2025-03-06T16:30:00+00:00": 210.1199951171875,
      "2025-03-06T17:30:00+00:00": 209.47999572753906,
      "2025-03-06T18:30:00+00:00": 210.0800018310547,
      "2025-03-06T19:30:00+00:00": 210.73890686035156,
      "2025-03-06T20:30:00+00:00": 210.63999938964844
    },
    "sentiment": 0.9497897624969482
  },
  {
    "title": "AbbVie Inc. (ABBV) TD Cowen 45th Annual Health Care Conference (Transcript)",
    "published": 1741186780,
    "day_prices": {
      "2025-03-05T14:30:00+00:00": 207.07000732421875,
      "2025-03-05T15:30:00+00:00": 208.3300018310547,
      "2025-03-05T16:30:00+00:00": 209.01499938964844,
      "2025-03-05T17:30:00+00:00": 209.5,
      "2025-03-05T18:30:00+00:00": 210.27000427246094,
      "2025-03-05T19:30:00+00:00": 211.9499969482422,
      "2025-03-05T20:30:00+00:00": 211.5800018310547
    },
    "sentiment": 0.933289110660553
  },
  {
    "title": "Johnson & Johnson: No More Tears, Just Gains In Intra-Cellular Acquisition",
    "published": 1741173872,
    "day_prices": {
      "2025-03-05T14:30:00+00:00": 207.07000732421875,
      "2025-03-05T15:30:00+00:00": 208.3300018310547,
      "2025-03-05T16:30:00+00:00": 209.01499938964844,
      "2025-03-05T17:30:00+00:00": 209.5,
      "2025-03-05T18:30:00+00:00": 210.27000427246094,
      "2025-03-05T19:30:00+00:00": 211.9499969482422,
      "2025-03-05T20:30:00+00:00": 211.5800018310547
    },
    "sentiment": 0.8795713186264038
  },
  {
    "title": "AbbVie Inc. stock underperforms Tuesday when compared to competitors",
    "published": 1741105860,
    "day_prices": {
      "2025-03-04T14:30:00+00:00": 214.47000122070312,
      "2025-03-04T15:30:00+00:00": 214.39630126953125,
      "2025-03-04T16:30:00+00:00": 211.83999633789062,
      "2025-03-04T17:30:00+00:00": 209.9949951171875,
      "2025-03-04T18:30:00+00:00": 209.1999969482422,
      "2025-03-04T19:30:00+00:00": 209.02999877929688,
      "2025-03-04T20:30:00+00:00": 209.05499267578125
    },
    "sentiment": 0.938363790512085
  },
  {
    "title": "SKYRIZI\u00ae (risankizumab) Now Available for Moderately to Severely Active Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease",
    "published": 1741075331,
    "day_prices": {
      "2025-03-04T14:30:00+00:00": 214.47000122070312,
      "2025-03-04T15:30:00+00:00": 214.39630126953125,
      "2025-03-04T16:30:00+00:00": 211.83999633789062,
      "2025-03-04T17:30:00+00:00": 209.9949951171875,
      "2025-03-04T18:30:00+00:00": 209.1999969482422,
      "2025-03-04T19:30:00+00:00": 209.02999877929688,
      "2025-03-04T20:30:00+00:00": 209.05499267578125
    },
    "sentiment": 0.9450487494468689
  },
  {
    "title": "AbbVie Inc. stock underperforms Monday when compared to competitors despite daily gains",
    "published": 1741019460,
    "day_prices": {
      "2025-03-03T14:30:00+00:00": 209.97999572753906,
      "2025-03-03T15:30:00+00:00": 210.9499969482422,
      "2025-03-03T16:30:00+00:00": 211.14999389648438,
      "2025-03-03T17:30:00+00:00": 211.4550018310547,
      "2025-03-03T18:30:00+00:00": 211.4149932861328,
      "2025-03-03T19:30:00+00:00": 211.0,
      "2025-03-03T20:30:00+00:00": 211.17999267578125
    },
    "sentiment": 0.8676826357841492
  },
  {
    "title": "AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.",
    "published": 1740996273,
    "day_prices": {
      "2025-03-03T14:30:00+00:00": 209.97999572753906,
      "2025-03-03T15:30:00+00:00": 210.9499969482422,
      "2025-03-03T16:30:00+00:00": 211.14999389648438,
      "2025-03-03T17:30:00+00:00": 211.4550018310547,
      "2025-03-03T18:30:00+00:00": 211.4149932861328,
      "2025-03-03T19:30:00+00:00": 211.0,
      "2025-03-03T20:30:00+00:00": 211.17999267578125
    },
    "sentiment": 0.862285852432251
  },
  {
    "title": "AbbVie and Gubra Announce License Agreement to Develop an Amylin Analog for the Treatment of Obesity",
    "published": 1740964324,
    "day_prices": {
      "2025-03-03T14:30:00+00:00": 209.97999572753906,
      "2025-03-03T15:30:00+00:00": 210.9499969482422,
      "2025-03-03T16:30:00+00:00": 211.14999389648438,
      "2025-03-03T17:30:00+00:00": 211.4550018310547,
      "2025-03-03T18:30:00+00:00": 211.4149932861328,
      "2025-03-03T19:30:00+00:00": 211.0,
      "2025-03-03T20:30:00+00:00": 211.17999267578125
    },
    "sentiment": 0.8817276954650879
  }
]